Transcript
  • PhenoPathDiagnoses you can count on®

    Diagnoses you can count on®www.phenopath.com

    henoPath provides anatomic pathology services for Phase I–III clinical trials. Our team adapts its service delivery to reflect your project design, management and implementation requirements.

    PhenoPath is experienced in working with third-party vendors to ensure timely and trackable specimen management, either directly from sponsor sites or another CRO.

    PhenoPath understands the need for timely results on entrance criteria testing, and provides rapid turnaround time for biomarker-testing assays. Board-certified pathologists and/or scientists evaluate all assays. Report formats are customizable to reflect either individual case or cumulative case formats.

    PATHOLOGY SERVICES

    DIAGNOSIS & INTERPRETATION• Solidtumordiagnosisandsubtyping,includingbreast,colon,lung,sarcoma,etc.• Hematopathologydiagnosisandsubtypingincluding,lymphoid,myeloid,plasmacelldisorders,etc.• Tissuebiomarkerquantification,includingflowcytometry,immunohistochemistry(IHC),immunofluorescence(IF),

    cytogenetics,fluorescencein situhybridization(FISH),chromogenicin situhybridization(CISH),DNA/RNAin situhybridization(ISH),andpolymerasechainreaction(PCR)

    • Tissuemacrodissectionfordownstreamassay(s)• Tissuemicroarrayconstruction• Over450testsavailable

    EXPERT CONSULTATION• Consultationontherapeutictargetselectionandquantificationinthepre-clinicalsetting• Consultationonallpathology-relatedaspectsofclinicaltrialdesign,includingoptimizedtherapeutictargetquantification• Secondopinionconsultationoncomplexcases,includingclinicalcorrelation

    CONTINUOUS EDUCATION• PhenoPathpathologistsfollowthelatestdevelopmentsincancerdiagnosisandtreatment• PhenoPathpathologistspublishextensivelyinscientificpeer-reviewedjournals• PhenoPathPathology Reference Guideavailable• PhenoPathpathologistsareavailabletopresenton-siteatinvestigatormeetings

    ENTRANCE & ENROLLMENT

    RAPID ENTRANCE CRITERIA SCREENING• Rapidpathologytestingandevaluationbyboard-certifiedpathologistsandscientists• Closecoordinationwitheachsponsor's clinicaltrialorganizers

    REPORTING CAPABILITIES• Customreportformats• Scalableandconfigurableresultsreportingdatabase• Virtualpathologyreportingcapabilities• Secureandencrypteddatatransferandarchiving

    SPECIMEN MANAGEMENT• End-to-endspecimenacquisitionandtracking• Rapid-turnaroundtimeforenrollmentcriteria

    CLINICAL TRIALS

    PD-L1 by IHC

    PP

  • vNov2015

    PhenoPathDiagnoses you can count on®

    SOLID TUMOR PATHOLOGY HEMATOPATHOLOGY

    Diagnosisandsubtyping(breast,colon,lung,sarcoma,etc.) IndolentBcellnon-Hodgkinlymphoma

    Undifferentiatedmalignantneoplasms Prognosticandpredictivemarkers

    Carcinomasofunknownprimarysite AggressiveBcellnon-Hodgkinlymphoma

    Spindlecelltumors/sarcomasubtyping Tcellnon-Hodgkinlymphoma

    Mesotheliomavs.adenocarcinoma Lymphoblasticleukemia/lymphoma

    Small,blue,roundcelltumors Hodgkinlymphoma

    Germcellneoplasms Plasmacellneoplasms

    Skinandmucosalimmunofluorescencestudies Acutemyeloidleukemias

    Chronicmyeloidneoplasms(MDS&MPN) Rarehematolymphoidneoplasms

    Hydatidiformmoleevaluation Benignhematolymphoidproliferations

    Amyloidsubtyping

    • PhenoPathhasanindependent,on-siteQualityAssuranceUnit(QAU)withseveraldecadesofcombinedexperienceinCLIA,GLPandGCPenvironments

    • ComprehensiveQualityManagementSystem,including:» AllprocessesgovernedbySOPs» Changecontrolprocess» Proceduresforpreventativeandcorrectiveactions(CAPA)» Qualitymetrics» Competencyassessmentsoftechnicalstaff

    REGULATORY COMPLIANCE• CAPaccreditationforhigh-complexitytestingunderCLIA• LicensedlaboratoryinCA,FL,MD,NY*,RI,andWA(*subset of services)• StudiesperformedinaccordancewithGLP/GCP,asapplicable• ClinicalTrialactivitiesatPhenoPathwillbeconductedaccordingtoPhenoPath'sStandardOperatingProcedure(SOPs)and

    thefollowing:» ICHGuidelineforGoodClinicalPractice(E6)» GoodClinicalLaboratoryPracticesasoutlinedintheWHO"GoodClinicalLaboratoryPracticesGuideline"» EuropeanMedicinesAgency(EMA)"ReflectionPaperforLaboratoriesthatPerformtheAnalysisorEvaluationofClinicalTrialSpecimens."

    EXPERTISE

    QUALITY

    IMP3 by IHC

    If you would like more information about PhenoPath's BioPharma services, please visit our web site at www.phenopath.com, contact any of our pathologists (888-927-4366), or contact your sales representative to request a quote.


Top Related